Health

Vacuum Lancing Technology Enters the UAE, Making Virtually Painless Glucose Checks a Possibility for Emiratis Living With Diabetes

Leave a comment



TUALATIN, Ore. (PRWEB)

Genteel LLC, one of the largest Bioscience & Health Technology companies in the Pacific Northwest, is improving health outcomes for diabetics far beyond the US. The vacuum lancing device manufacturer announces another international distribution partnership, this time in the United Arab Emirates with DiapointME.

Genteel manufactures the only vacuum lancing device FDA-cleared for use anywhere on the body. With blood sample readings from palms matching those of sensitive fingertips, Genteel significantly reduces pain associated with blood glucose monitoring.

Genteel LLC is proud to announce that their technology is now available to a population in great need of improved diabetes management. According to statistics from the International Diabetes Federation, the UAE holds one of the highest prevalence of diabetes globally. Nearly half of the adult population with type 2 diabetes mellitus are still undiagnosed and untreated.

DiapointME, headquartered in Dubai, is a space for diabetes advocacy, education, and products. As an authorized distributor of the Genteel lancing device, they have joined the Genteel mission of providing relief from discomfort and fear through comfortable glucose checks. Vice President of Sales and Marketing, Mark Berkovich, commented on the deal saying, “I am absolutely thrilled to bring the Genteel solution to more people. Through the pursuit of less pain, we are improving patient adherence, and ultimately health outcomes for those who need it most”

About Genteel

Genteel LLC is the leader in premium painless vacuum blood draw lancing devices. With over 27 worldwide patents granted in its technology, their unique and gentle device has helped tens of thousands of people living with diabetes give their fingers a break. Learn more about Genteel here.

Share article on social media or email:

Leave a Reply